65,437 trials
Type 2 Diabetes Mellitus
Primary: Mean Change From Baseline in Plasma HbA1c (Glycosylated Hemoglobin / Hemoglobin A1c) — -0.38; -0.26; -0.25; -0.30 percent
ADHD Specifically With Executive Function Impairment
Primary: Change From Baseline in Subject-reported Behavior Rating Inventory of Executive Function - Adult Version Global Executive Composite T-score (BRIEF-A GEC T) at up to 10…
Joint Diseases · Arthritis · Osteoarthritis
Primary: 5-Day Sum of Pain Intensity Difference (SPID5) — 98.6; 153.1; 161.8; 218.4 Units on a scale — p=0.007
Idiopathic Thrombocytopenic Purpura · Thrombocytopenia · Thrombocytopenic Purpura
Primary: Adverse Events — 162; 215 participants
Venous Thromboembolism
Primary: Physician's Assessment of Efficacy of Treatment — 432; 44; 2; 2 Participants
Pulmonary Arterial Hypertension · Hypertension, Pulmonary
Primary: Number of Participants With Any Adverse Event — 21 participants
Diffuse Intrinsic Pontine Glioma
Primary: Two Year Survival of Pediatric Patients With Diffuse Pontine Gliomas — 14.29 Percentage of patients
Pneumococcal Disease · 13-valent Pneumococcal Vaccine
Primary: Percentage of Participants Achieving Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Antibody Level ≥0.35 Micrograms Per Milliliter (Mcg/mL) 1 Month After the…
Obesity · Vitamin D Deficiency · Psychosis
Primary: Change in Weight — 0.07 kilograms
Glabellar Frown Lines
Primary: Responder by Independent Rater's Assessment at Maximum Frown at Week 4 — 267; 89 participants
Hearing Loss
Primary: Comparison of Pre-implant Consonant-Nucleus-Consonant (CNC) Scores to Post-implant CNC Scores in Bilateral Users. — 4.0; 69.0 percent of words correct
Lymphedema
Primary: Median Time to Wound Closure at 9 Months — 141; 211 median number of days for complete heali
Growth & Development · Child Development · Internship and Residency
Primary: Presence of Resident Surveillance Behaviors of Specific Aspects of Developmental Status at the Two Month Preventive Care Visit — 3 Participants
Epilepsy · Epilepsy, Generalized · Seizures
Primary: Percent Reduction in Number of Drop Seizures (12-week Maintenance Period). — 41.2; 49.4; 68.3; 12.1 Percent Reduction — p=0.0120
Presbyopia
Primary: Overall Convenience With Contact Lenses — 82.4 Percentage of participants